Recombinant hGM-CSF Herpes Simplex Virus
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant hGM-CSF Herpes Simplex Virus, covering 2016-09-01 to 2016-09-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer [Phase 1]